Personalized support for people with opioid use disorder and chronic pain
Tailored Retention and Engagement for Effective integrated Treatment of OUD and Pain (TREETOP)
This program offers tailored pain self-management plus extra engagement supports to help people with opioid use disorder and long-term pain stay in treatment and feel better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11161498 on NIH RePORTER |
What this research studies
You might be invited to join one of two randomized trials that adapt a pain self-management program specifically for people who have both chronic pain and opioid use disorder. The program pairs medication treatment (like buprenorphine when appropriate) with tailored coaching, outreach, and strategies to help you manage pain and remain in care. A stakeholder board made up of patients, community members, and policymakers helps shape how the program is delivered and how we keep people engaged. The work is happening across clinics in Appalachia (Pennsylvania and West Virginia), Oregon, and Baltimore and may include in-person and remote options.
Who could benefit from this research
Good fit: Adults who have opioid use disorder and co-occurring chronic pain, including people receiving or eligible for medications like buprenorphine at participating clinics.
Not a fit: People who do not have both OUD and chronic pain, or who are not willing to try self-management strategies or medication-based treatment, are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, this approach could improve pain control, increase staying in treatment, and reduce opioid-related harms for people with both conditions.
How similar studies have performed: Integrated medication and behavioral pain-management approaches have shown promise, but multi-site tailored retention strategies like these are relatively new.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Winstanley, Erin L — University of Pittsburgh at Pittsburgh
- Study coordinator: Winstanley, Erin L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.